AWAG
BIIB icon

ARS Wealth Advisors Group’s Biogen BIIB Stock Holding History

ARS Wealth Advisors Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-846
Closed -$241K – 147
2023
Q2 		$241K Sell
846
-764
-47% -$227K 0.04% 129
2023
Q1 		$448K Sell
1,610
-210
-12% -$58.1K 0.08% 85
2022
Q4 		$504K Buy
1,820
+33
+2% +$9.32K 0.08% 87
2022
Q3 		$477K Sell
1,787
-364
-17% -$77.3K 0.07% 97
2022
Q2 		$439K Sell
2,151
-438
-17% -$89.5K 0.06% 111
2022
Q1 		$545K Buy
2,589
+331
+15% +$72K 0.1% 77
2021
Q4 		$542K Buy
2,258
+349
+18% +$89.7K 0.09% 82
2021
Q3 		$540K Buy
+1,909
New +$626K 0.1% 78

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ARS Wealth Advisors Group's BIIB Position: Q3 2023 in Review

ARS Wealth Advisors Group sold out of Biogen (BIIB) in Q3 2023, closing a stake of 846 shares — an estimated $241K sold.

ARS Wealth Advisors Group first reported a position in BIIB in Q3 2021 and held it in 8 quarters. The position peaked at $545K in Q1 2022. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • ARS Wealth Advisors Group reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • ARS Wealth Advisors Group sold 846 Biogen shares in Q3 2023, an estimated $241K.
  • ARS Wealth Advisors Group first reported a position in Biogen in Q3 2021 and held it in 8 quarters.
  • ARS Wealth Advisors Group's Biogen position peaked at $545K in Q1 2022.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on ARS Wealth Advisors Group's 13F filing for Q3 2023, filed 26 Oct 2023.